Zingibain

Zingibain (Ginger Protease): A Comprehensive Reference

1. Identity

1.1 Names, Classification, and Enzyme Nomenclature

Zingibain, also known as zingipain or ginger protease (EC 3.4.22.67), is a cysteine protease enzyme found in ginger (Zingiber officinale) rhizomes. The name "zingibain" follows the conventional nomenclature applied to plant cysteine proteases — the suffix -ain being shared with related enzymes such as papain and ficin. The alternate name zingipain appears in some biochemical literature and enzyme databases.

Ginger protease is a cysteine protease belonging to peptidase family C1 (papain family), which is characterized by a cysteine residual at the active center of the enzyme. As a member of the papain-like protease family of cysteine proteases, zingibain shares several structural and functional similarities with more well-studied enzymes such as papain, bromelain, and actinidin.

1.2 Botanical Source

The enzyme is naturally sourced from the rhizome of the ginger plant (Zingiber officinale), where it constitutes a key component of the plant's proteolytic system. Zingiber officinale belongs to the family Zingiberaceae, a broad family of tropical monocotyledonous flowering plants that also includes turmeric (Curcuma longa), cardamom, and galangal.

1.3 Two Distinct Molecular Forms

Zingibain catalyses the preferential cleavage of peptides with a proline residue at the P2 position. It has two distinct forms, ginger protease I (GP-I) and ginger protease II (GP-II). The complete amino-acid sequence of GP-II, a glycoprotein containing 221 amino acids, and about 98% that of GP-I have been determined. Both proteases, which are 82% similar, have cysteine residues at position 27 and histidines at position 161, corresponding to the essential cysteine-histidine dyads found in the papain family of cysteine proteases, and six corresponding cysteine residues that form the three invariant disulfide linkages seen in this family of proteins.

The sequence homology with other members (papain, bromelain, actinidin, protease omega, etc.) of this family is approximately 50%. GP-II has two predicted glycosylation sites at Asn99 and Asn156.

It is a monomeric protein of 33.8 kDa and its isoelectric point is 4.38.

1.4 Natural Forms and Preparations

Zingibain is predominantly extracted from fresh ginger rhizomes, as drying processes can lead to reduced enzymatic activity due to heat-induced denaturation and loss of stability. In research and laboratory settings, ginger protease has been extracted from ginger rhizome by homogenization with 100 mM potassium phosphate buffer pH 7.0 containing 10 mM cysteine and 5 mM EDTA, which were found to be the most efficient extraction buffer and stabilizers.

In comparison with other natural tenderizing agents, the commercial use of zingibain is at a minimal level due to its low stability; treating with sodium ascorbate or preparing as ginger protease acetone powders extends the shelf life from 2 days to 18 months at storage of 5°C. In food-industry contexts, the enzyme is also encountered as a crude ginger powder, a freeze-dried extract, or as a semi-purified preparation.

2. Historical and Traditional Use

2.1 Ginger's Deep Roots in Asian Medicine

Ginger (Zingiber officinale) has been employed in traditional medicine across Asian cultures, including India and China, for over 5,000 years to address various health issues, particularly digestive ailments such as nausea, bloating, and indigestion. Ancient Chinese texts dating back to approximately 500 BCE document its use as a tonic for stomach disorders, with early practitioners noting effects on gastrointestinal relief.

Although ginger's traditional use was attributed broadly to the plant's aromatic and pungent constituents (especially gingerols and shogaols), the proteolytic effect of what is now known as zingibain was exploited empirically long before its scientific characterization — most notably in culinary traditions involving meat and milk preparation.

2.2 Culinary-Traditional Use: Meat and Milk

This cysteine protease found in the rhizome has been used for meat tenderization across Asian cuisines for generations. In southern Chinese folk tradition, curdled ginger milk is made using ginger protease, since it is thought to have good milk-clotting activity. This application — essentially using fresh ginger juice or rhizome pulp to coagulate warm milk into a dessert curd — represents one of the oldest practical applications of the enzyme, predating by centuries any formal knowledge of its biochemical basis.

2.3 Scientific Discovery and Naming

The modern scientific discovery of zingibain, the primary cysteine protease in ginger rhizomes, occurred in the 1970s amid growing interest in plant-derived enzymes. It was first identified and named "zingibain" by Thompson et al. in 1973, who demonstrated its potent proteolytic activity on proteins like casein and hemoglobin, establishing ginger as a novel source of plant-derived protease. Ginger protease (also known as Zingibain, EC 3.4.22.67) is a plant protease from the ginger rhizome, Zingiber officinale Roscoe, first reported by Thompson et al., in the Journal of Food Science (1973, 38:652–655).

3. Key Biochemical Constituents and Mechanisms of Action

3.1 Molecular Structure and Catalytic Mechanism

These peptidases contain an active cysteine residue in their centers that catalyzes the hydrolytic cleavage of peptide bonds. The catalytic mechanism is a nucleophilic attack by the thiol group of the active-site cysteine upon the carbonyl carbon of the susceptible peptide bond, forming a thioester intermediate that is subsequently hydrolyzed by water. In this group of proteases, a thiol group of a cysteine residue is the nucleophilic group involved in attacking and hydrolyzing a peptide bond.

Zingibain is noted for its activity as both a proteinase and a collagenase. Its most biochemically remarkable feature is its cleavage specificity: a cysteine protease from ginger rhizome (GP-II) cleaves peptides and proteins with proline at the P2 position. The unusual specificity for proline makes GP-II an attractive tool for protein sequencing and identification of stably folded domains.

Zingibain is a proline-specific cysteine protease. Accordingly, Zingibain is effective in any situation wherein the target is a proteinaceous molecule that comprises a significant percentage of proline residues. Collagen is among the most proline-rich proteins in animal biology, which directly explains zingibain's pronounced collagenolytic activity.

3.2 Biochemical Properties

The enzyme exhibited maximal proteolytic activity at a temperature of 60 °C and pH 7.0. It was found to be stable at 40–65 °C during 2 hours. The enzyme was found to be highly stable against numerous metal ions and its activity was enhanced by Ca²⁺, K⁺ and Na⁺. It was completely inhibited by heavy metal ions such as Cu²⁺ and Hg²⁺ and partially by Cd⁺.

The ginger protease was protected by dithiothreitol during extraction and reaction, indicating the involvement of –SH groups at the active site. This confirms the enzyme's classification as a thiol (cysteine) protease, consistent with inhibition by sulfhydryl-reactive agents. Detergents such as sodium dodecyl sulfate increased the activity of ginger protease, while Tween 80 and Tween 20 slightly reduced the activity.

3.3 Collagenolytic Activity: A Unique Property

Zingibain is the only catalogued plant protease with collagenolytic activity. The 2007 study by Kim, Hamilton, Guddat, and Overall confirmed the molecular basis of this activity: two cysteine proteases, GP2 and GP3, have been isolated from ginger rhizomes (Zingiber officinale). GP2 is virtually identical to a previously identified ginger protease GPII [K.H. Choi and R.A. Laursen, Eur. J. Biochem. 267 (2000) 1516–1526], and cleaves native type I collagen at multiple discrete sites, which are in the interior of the triple helical region of this molecule.

Hydrolysis of collagen appears to be higher with zingibain protease compared with that of myofibrillar proteins. The proteolysis of structural proteins in meat results in improved tenderness.

3.4 Milk Coagulation Properties

Zingibain (EC 3.4.22.67) is a coagulant cysteine protease and a meat tenderizer agent that has been reported to produce satisfactory final products in dairy and meat technology, respectively. As a rennet substitute, zingibain coagulates milk proteins by specifically cleaving κ-casein at bonds such as Ala90-Glu91 and His102-Leu103, facilitating gel formation for cheese production. Its milk-clotting activity (MCA) is optimal at pH 6.0–6.5 and 70°C, with an MCA:proteolytic activity ratio of 44–47, which is comparable to chymosin in efficiency for casein hydrolysis under similar acidic conditions, though it exhibits higher thermal stability up to 65°C.

3.5 Bioactive Peptide Generation

The amino acid residues at the P2 position in peptides generated by ginger protease were Pro (66.91%) and Hyp (14.71%), which was due to the activity of ginger protease preferentially cleaving peptide bonds towards Pro and Hyp at the P2 position. Additionally, the results showed that Ala accounted for a small part (9.56%), indicating ginger protease can also recognize Ala at the P2 position.

The ginger protease-degraded collagen hydrolysate (GDCH) exhibited the highest degree of hydrolysis (20.37%) and DPPH radical scavenging activity (77.73%), and in vivo experiments showed that the GDCH was more efficiently absorbed by the gastrointestinal tract. Further oral administration experiments revealed that GDCH was not entirely degraded to free amino acids and can be partially absorbed as dipeptides.

3.6 Biological Stress Responses Within the Plant

Within the ginger plant itself, zingibain can also respond to abiotic and biotic stresses, such as heat shock, cold temperatures, and dehydration, to eliminate any resulting misfolded or denatured proteins. This positions zingibain not merely as a digestive enzyme but as part of the plant's broader protein quality-control machinery.

4. Scientific Evidence by Area of Application

4.1 Meat Tenderization

Evidence strength: Moderate-to-strong (food science literature); predominantly laboratory and food-processing studies, with limited randomized human sensory trials.

The most extensively researched application of zingibain is as a meat tenderizer. When added to cooking meat, usually within raw or dried ginger, zingibain has been shown to increase the tenderness of meat. Meat tenderization occurs due to zingibain's rapid proteolysis of major muscle proteins within meat, especially actomyosin and Type I collagen, which is found in muscle joints.

While other papain enzymes, including papain, ficin, and bromelain, are more commonly used to tenderize meat, zingibain shows similar or elevated proteolytic activity. While papain can hydrolyze actomyosin, it also breaks down other major tissue proteins, leading to a mushy meat texture. The specificity of zingibain's binding ensures predominant hydrolyzation of actomyosin and Type I collagen.

A comparative study reported by Ha et al. (2012, Food Chemistry) assessed commercial preparations of papain, bromelain, actinidin, and zingibain for their activities toward meat proteins. Four commercially available plant preparations containing respectively papain, bromelain, actinidin and zingibain were evaluated for their ability to hydrolyze proteins present in both beef connective tissue and topside myofibril extracts. The results show significant differences in protease activity depending on the assay used, and that protease assays with connective tissue and meat myofibril extracts provide a realistic evaluation of the potential of the enzymes for application in meat tenderization. The actinidin protease preparation was found to be most effective at hydrolyzing beef myofibril proteins, and the zingibain protease preparation most effective at hydrolyzing connective tissue proteins. This indicates the potential of these proteases for targeting specific tenderizing applications, in contrast to trying to achieve control of tenderization with the more active papain and bromelain proteases.

Naveena et al. (2004) compared the tenderizing effects of different plant enzymes on tough buffalo meat: they found that cheaper and easily available ginger rhizome could effectively be used for tenderization of tough meat. They compared the tenderizing effect of 2% cucumis extract, 5% ginger extract, or 0.2% papain on tough buffalo meat and found that the shear force value was significantly lower in all the treatments compared to the control, which was due to the increase in the solubility of collagen, sarcoplasmic and myofibrillar proteins.

One study identified zingibain, the enzyme found in ginger, as the most effective for tenderizing beef (p < 0.05). In contrast, actinidin, the enzyme present in kiwi, was found to be the most effective for tenderizing goose and rabbit meats.

Studies on chicken have also been conducted: in poultry, 5% w/v crude ginger extract injected into chicken breast muscle reduces shear force (p < 0.05) and increases myofibrillar fragmentation, leading to improved tenderness comparable to other plant proteases like bromelain.

Applied to older, lower-quality beef, the longer cooking time (12 hours) with ginger protease injection treatment caused over-tenderization of the meat. The soft texture associated with over-tenderization may be suitable for some specialized consumer markets, for instance, the elderly population with chewing difficulties. Improving the eating quality of low-quality meat from old animals through sous vide cooking and the use of ginger proteases may increase the acceptability of lower-value beef, potentially enhancing the commercial value of carcasses typically produced in the beef industry.

The application of plant crude extracts or powders containing higher levels of compounds exerting tenderizing effects is also gaining popularity due to lower cost, improved sensory attributes of meat, and the presence of bioactive compounds exerting additional benefits in addition to tenderization, such as antioxidants and antimicrobial effects. However, the uncontrolled action of plant proteases could cause excessive tenderization (mushy texture) and poor quality due to an indiscriminate breakdown of proteins. The higher cost of separation and the purification of enzymes, unstable structure, and poor stability of these enzymes due to autolysis are some major challenges faced by the food industry.

4.2 Milk Coagulation and Dairy Technology

Evidence strength: Preliminary-to-moderate (food science/biochemical studies); no human clinical trials.

Zingibain is considered a green and safe food additive for industrial applications, including wine clarification, milk curdling, and meat tenderization. Zingibain milk-clotting activity (MCA) was found to be highly stable when stored under freezing (−20 °C) for 30 days, compared to at 4 °C.

While the potential exists for using zingibain more extensively in food processing (milk-clotting or meat tenderizing) and other biotechnological processes, fast and efficient purification methods are scarce. In zingibain extraction and purification processes, most of the techniques involve a combination of two or more steps. These purification protocols are too complicated to be used as simple and effective industrial methods.

4.3 Production of Bioactive Collagen Hydrolysates

Evidence strength: Preliminary (laboratory and animal studies); no human clinical trials directly attributing effects to zingibain-generated peptides.

A 2022 PMC study examined zingibain-degraded collagen hydrolysate (GDCH) in comparison with hydrolysates generated by pepsin, alkaline protease, and bromelain. An integrated strategy, including in vitro study (degree of hydrolysis and DPPH radical scavenging activity) and in vivo study (absorption after oral administration in rats), was developed to evaluate the properties of the fish skin gelatin hydrolysates prepared using different proteases. Meanwhile, in order to identify the hydrolysis site of ginger protease, the peptides in the GDCH were comprehensively characterized by liquid chromatography/tandem mass spectrometry (LC-MS) method. The GDCH exhibited the highest degree of hydrolysis (20.37%) and DPPH radical scavenging activity (77.73%), and in vivo experiments showed that the GDCH was more efficiently absorbed by the gastrointestinal tract.

Many studies have shown that ginger protease-degraded collagen hydrolysate (GDCH) can be used as a functional food for patients with obesity, osteoporosis, gastrointestinal dysfunction, and type 2 diabetes. However, it is critical to note that these references concern animal model data and in vitro cell studies; no dedicated human clinical trials have established zingibain-derived hydrolysate as a proven therapeutic intervention for these conditions.

As compared with other commercial enzymes, ginger protease is reported to have a unique substrate specificity for recognizing Pro at the P2 position. Thus, researchers have speculated that bioactive peptides might be generated by ginger protease due to its unique hydrolysis site. This specificity means that zingibain-generated peptides may have a distinct peptide profile relative to bromelain- or papain-generated hydrolysates, which could have implications for biological activity — though human clinical validation is lacking.

4.4 Acetylcholinesterase Inhibition

Evidence strength: Very preliminary (in vitro/enzyme kinetics only); no human clinical trials.

A study (published in Applied Biochemistry and Biotechnology, 2013) investigated ginger-family plants as sources of acetylcholinesterase inhibitors (AChEIs). In order to search for new acetylcholinesterase inhibitors, 15 Zingiberaceae plants were tested for AChEI activity in rhizome extracts. The crude homogenate and ammonium sulfate cut fraction of Zingiber officinale contained a significant AChEI activity. In-gel tryptic digestion with liquid chromatography-tandem mass spectroscopy resolution revealed two heterogeneous peptides, a 16-amino-acid-long fragment with 100% similarity to zingipain-1, which is a cysteine protease from Z. officinale, and a 9-amino-acid-long fragment that was 100% identical to actinidin Act 2a, suggesting that the preparation was heterogeneous. The AChEI exhibited noncompetitive inhibition of AChE for the hydrolysis of acetylthiocholine iodide with a K_i value of 9.31 mg/ml.

The enzyme has cysteine protease activity, but also a significant acetylcholinesterase inhibitor activity, exhibiting noncompetitive inhibition of acetylcholinesterase for the hydrolysis of acetylthiocholine iodide with a K_i value of 9.31 mg/ml. This is a purely in vitro finding; its relevance to in vivo cholinergic neurotransmission or neurological conditions such as Alzheimer's disease in humans has not been demonstrated.

4.5 Antiproliferative Activity Against Fungi and Cancer Cell Lines

Evidence strength: Very preliminary (in vitro cell culture); no human clinical evidence.

Research on cysteine proteases from related Zingiber species (most closely, Zingiber ottensii) has identified antiproliferative properties. Zingipain shows antiproliferative activities against fungi, i.e. Fusarium oxysporum, Exserohilum turicicum, and Collectotrichum cassicola, and human malignant cell lines, e.g. Hep-G2 and SW-620, although not against bacterial cells. These findings are from cell culture assays and have not been replicated in animal or human studies. They should not be interpreted as evidence of anti-cancer efficacy.

4.6 Anti-Inflammatory Activity (Ginger Broadly; Not Zingibain Specifically)

Evidence strength: The broader Zingiberaceae family (and ginger) has a body of clinical evidence for anti-inflammatory and analgesic effects, but this evidence is attributed to gingerols, shogaols, and related phenolic compounds — not specifically to zingibain.

Findings across systematic reviews indicate that Zingiberaceae extracts are clinically effective hypoalgesic agents, and the available data show a better safety profile than non-steroidal anti-inflammatory drugs. However, both non-steroidal anti-inflammatory drugs and Zingiberaceae have been associated with a heightened bleeding risk, and there have been no comparator trials of this risk. Further clinical studies are recommended to identify the most effective type of Zingiberaceae extract and rigorously compare safety, including bleeding risk.

A 2024 review in Nutrients (Szymczak et al.) examined ginger's anti-arthritic potential: many of the bioactive components of ginger may have therapeutic benefits in treating inflammatory arthritis. Their properties seem especially helpful in treating diseases linked to persistent inflammation and pain, symptoms present in the course of the most prevalent rheumatic diseases, such as osteoarthritis (OA) and rheumatoid arthritis (RA). However, these benefits are principally attributed to ginger's phenolic phytochemicals. No published human trial has isolated zingibain as the specific agent responsible for anti-inflammatory outcomes. The European Patent application EP1729593A1 raised the hypothesis that zingibain itself could have anti-inflammatory properties as a food improver, but this has not been validated in clinical settings.

5. Body Systems and Health Areas of Association

• Digestive / Gastrointestinal System: As a food-derived protease, zingibain contributes to protein hydrolysis during digestion when ingested via fresh or minimally processed ginger. Studies on ginger protease-derived collagen hydrolysate suggest improved gastrointestinal absorption of peptides.
• Musculoskeletal System: Zingibain's collagenolytic and proteolytic activity on connective tissue proteins (Type I collagen, actomyosin) is well documented in food science, with proposed relevance to joint and connective-tissue health through generation of collagen-derived peptides — though human evidence for a therapeutic effect is not established.
• Metabolic Health: Ginger protease-degraded collagen hydrolysate (GDCH) significantly decreases triglyceride (TG) and cholesterol (CHO) levels in blood and adipocyte size in white adipose tissue compared to control — in animal (rodent) studies only.
• Central Nervous System (Exploratory): The in vitro acetylcholinesterase inhibitory activity described above places zingibain in an exploratory relationship with cholinergic neuroscience, but no clinical relevance has been established.
• Oncology (Exploratory): Antiproliferative effects against specific cancer cell lines observed in vitro; no translational evidence in humans.

6. Dosage Forms and Dosages Reported in Studies

Zingibain as an isolated, standardized supplement is not approved or regulated as a therapeutic drug in any major jurisdiction, and there are no established clinical dosage regimens. The following are dosages reported in food-science and biochemical research contexts only:

• Meat tenderization (research applications): 2% cucumis extract, 5% ginger extract, or 0.2% papain on tough buffalo meat were compared. Application of 0.2% w/w ginger extract containing zingibain to beef has been shown to significantly decrease shear force and enhance tenderness without excessive proteolysis when controlled properly.
• Poultry: 5% w/v crude ginger extract injected into chicken breast muscle reduces shear force (p < 0.05) and increases myofibrillar fragmentation, leading to improved tenderness comparable to other plant proteases like bromelain.
• Extraction yield (laboratory): The extraction method yielded 0.94% (w/w of fresh weight) of ginger protease with a specific activity of 27.6 ± 0.1 Unit/mg protein, where 1 Unit is defined as the amount of protease causing an increase in absorbance by 1 unit per minute using azocasein as the substrate.
• AChEI study: The acetylcholinesterase inhibitory preparation exhibited noncompetitive inhibition of AChE with a K_i value of 9.31 mg/ml. This is an in vitro enzyme kinetics parameter and does not represent a human dosage.

No human clinical trials have established an efficacious or safe dose of isolated zingibain for any therapeutic purpose. Dosages used in functional food research are expressed as concentrations in food matrices, not as supplement doses.

7. Safety Considerations and Interactions

7.1 General Safety Profile

Zingibain is considered a green and safe food additive for industrial applications, including wine clarification, milk curdling, and meat tenderization. Ginger (Zingiber officinale) itself has a long history of safe food use and is generally recognized as safe (GRAS) by food regulatory agencies in multiple jurisdictions. However, safety data specifically on isolated or concentrated zingibain as a human supplement are not available from published clinical trials.

7.2 Enzyme Stability and Denaturation

Drying processes can lead to reduced enzymatic activity due to heat-induced denaturation and loss of stability. This means that commercially dried or powdered ginger contains substantially less active zingibain than fresh rhizome. Cooking temperatures sufficient to denature the enzyme (above approximately 70°C) will inactivate zingibain before it can act as an enzyme in the gastrointestinal tract, reducing any proteolytic activity to that of a denatured protein.

7.3 Inhibition by Heavy Metal Ions

Zingibain is completely inhibited by heavy metal ions such as Cu²⁺ and Hg²⁺ and partially by Cd⁺. This has no direct dietary safety implication under normal food consumption, but it is relevant in biochemical research settings and in scenarios where heavy metal exposure might be a concern.

7.4 Bleeding Risk (Class Effect of Zingiberaceae)

Both non-steroidal anti-inflammatory drugs and Zingiberaceae have been associated with a heightened bleeding risk, and there have been no comparator trials of this risk. This is a class effect attributed to ginger's broad phytochemical constituents (particularly gingerols) and is not specifically attributed to zingibain itself. Nonetheless, any preparation of concentrated ginger-derived materials should be considered in the context of this known class association.

7.5 Potential for Excessive Proteolysis

The uncontrolled action of plant proteases could cause excessive tenderization (mushy texture) and poor quality due to an indiscriminate breakdown of proteins. In the context of human supplementation, theoretically high doses of active proteolytic enzymes could affect mucosal or other proteins, though this has not been studied clinically for zingibain.

7.6 Stability, Storage, and Commercial Challenges

Zingibains were exclusively purified using chromatographic techniques with very low yield purification. The commercial use of zingibain is at a minimal level due to its low stability; treating with sodium ascorbate or preparing as ginger protease acetone powders extends the shelf life from 2 days to 18 months at storage of 5°C. This instability is a significant practical challenge for any supplement product purporting to deliver active zingibain.

7.7 Allergenicity

Ginger allergy, though uncommon, is reported. No specific allergenicity data for isolated zingibain protein are available from published clinical literature. Given that zingibain is a protein — the class of molecules most commonly responsible for food allergies — this is a theoretically relevant consideration in concentrated enzyme preparations, though it has not been formally characterized.

8. Current Research Gaps and Limitations

The scientific characterization of zingibain is robust at the biochemical and food-science level. Its molecular structure (including X-ray crystal structure determined at 2.1 Å resolution by Choi, Laursen, and Allen, PubMed PMID: 10512617), substrate specificity, and enzymatic kinetics are well understood. However, the following major gaps exist:

• No human clinical trials have investigated the safety or efficacy of isolated, standardized zingibain as a dietary supplement.
• The generation of bioactive peptides by zingibain has been demonstrated in vitro and in rodent models, but human bioavailability and biological effect studies are not yet available.
• Anti-inflammatory, neuroprotective, and anticancer effects attributed to zingibain (as opposed to ginger's broader phytochemistry) have been demonstrated only in cell cultures or enzyme assays.
• Optimal dosage, dosage forms, and routes of administration for any human application remain undefined in the published literature.
• Long-term safety data for concentrated zingibain preparations are absent.

References

• Thompson EH, Wolf ID, Allen CE. Ginger rhizome: A new source of proteolytic enzyme. Journal of Food Science. 1973;38:652–655.
• Wikipedia: Zingibain (enzyme overview, EC 3.4.22.67)
• Evaluating the Properties of Ginger Protease-Degraded Collagen Hydrolysate and Identifying the Cleavage Site of Ginger Protease by Using an Integrated Strategy and LC-MS Technology. PMC / Foods. 2022.
• Choi KH, Laursen RA, Allen KN. The 2.1 Å structure of a cysteine protease with proline specificity from ginger rhizome, Zingiber officinale. Biochemistry. 1999;38(36):11553–11559. PMID: 10512617.
• Choi KH, Laursen RA. Amino-acid sequence and glycan structures of cysteine proteases with proline specificity from ginger rhizome Zingiber officinale. Eur J Biochem. 2000;267(5):1516–26. PMID: 10691991.
• Huang XW, et al. Purification, characterization, and milk coagulating properties of ginger proteases. J Dairy Sci. 2011;94:2259–2269.
• Kim M, Hamilton SE, Guddat LW, Overall CM. Plant collagenase: Unique collagenolytic activity of cysteine proteases from ginger. Biochim Biophys Acta. 2007;1770(12):1627–1635. PMID: 17920199.
• Gagaoua M, Hoggas N, Hafid K. Data in support of three phase partitioning of zingibain, a milk-clotting enzyme from Zingiber officinale Roscoe rhizomes. Data in Brief. 2016;6:634–639. PMID: 26909379.
• Zingipain, a ginger protease with acetylcholinesterase inhibitory activity. Appl Biochem Biotechnol. 2013. PMID: 23625608.
• Nafi' A, et al. Properties of proteolytic enzyme from ginger (Zingiber officinale Roscoe). International Food Research Journal. 2013;20(1):553–558.
• Nafi' A, et al. Partial Characterization of an Enzymatic Extract from Bentong Ginger (Zingiber officinale var. Bentong). Molecules. 2014;19(8):12336–12348. PMC6271898.
• Rondanelli M, et al. Zingiberaceae extracts for pain: a systematic review and meta-analysis. BMC Complementary and Alternative Medicine. 2015;15:141. PMC4436156.
• Szymczak J, Grygiel-Górniak B, Cielecka-Piontek J. Zingiber officinale Roscoe: The Antiarthritic Potential of a Popular Spice—Preclinical and Clinical Evidence. Nutrients. 2024;16(5):741. PMC10933899.
• Application of Plant Proteases in Meat Tenderization: Recent Trends and Future Prospects. Foods. 2023. PMC10047955.
• European Patent EP1729593A1: Cysteine protease from ginger (Zingiber) as a food improver and anti-inflammatory.
• BRENDA Enzyme Database: EC 3.4.22.67 — Zingipain (Zingibain).
• Effect of proteases from ginger rhizome on the fragmentation of myofibrils and tenderness of chicken breast. LWT — Food Science and Technology. 2020.
• Improving tenderness and quality of M. biceps femoris from older cows through concentrate feeding, zingibain protease and sous vide cooking. Meat Science. 2021.